Publicação
Therapeutic deep eutectic solvents as solubility enhancers for different active pharmaceutical ingredients
| Resumo: | In recent years, deep eutectic solvents (DES) have emerged as a sustainable alternative to ionic liquids mainly due to their lower production costs and higher biodegradability/ biocompatibility(1). DES are defined as a mixture of organic compounds with a melting point significantly lower than that of either individual component(2). When based in natural compounds such as aminoacids, organic acids, sugars or choline derivatives, DES are so called natural deep eutectic solvents (NADES) which fully comply with green technology principles(3). NADES constituted by bioactive substances or active pharmaceutical ingredients (APIs), which we define as therapeutic deep eutectic solvents (THEDES), are a promising source for several pharmaceutical and biomedical applications due to their increased ability to dissolve model drugs by increasing their solubility, permeation and absorption. In this work, we synthetized several THEDES based in choline chloride (ChCl) or menthol conjugated with three different APIs: acetylsalicylic acid (AA), benzoic acid (BA) and phenylacetic acid (PA) with different molar ratios (ChCl:AA 1:1, ChCl:PA 1:1, Menthol:AA 3:1, Menthol:BA 3:1, Menthol:PA 2:1, Menthol:PA 3:1). All THEDES produced were characterized by differential scanning calorimetry and polarized optical microscopy. Dissolution studies performed in PBS for 24 hours shown that THEDES increased significantly the dissolution of all APIs studied compared to the control (APIs only). This increased solubility was even more noticeable for the cases of THEDES with menthol in their composition. In overall, our results suggest the great promise of using THEDES as solubility enhancers in the development of novel and more effective drug delivery systems. |
|---|---|
| Autores principais: | Silva, J. C. |
| Outros Autores: | Aroso, Ivo Manuel Ascensão; Mano, F.; Sá-Nogueira, I.; Barreiros, S.; Reis, R. L.; Paiva, Alexandre; Duarte, Ana Rita C. |
| Assunto: | Drug delivery systems Green chemistry Therapeutic deep eutectic solvents Ciências Médicas::Biotecnologia Médica |
| Ano: | 2015 |
| País: | Portugal |
| Tipo de documento: | outro |
| Tipo de acesso: | acesso aberto |
| Instituição associada: | Universidade do Minho |
| Idioma: | inglês |
| Origem: | RepositóriUM - Universidade do Minho |
| Resumo: | In recent years, deep eutectic solvents (DES) have emerged as a sustainable alternative to ionic liquids mainly due to their lower production costs and higher biodegradability/ biocompatibility(1). DES are defined as a mixture of organic compounds with a melting point significantly lower than that of either individual component(2). When based in natural compounds such as aminoacids, organic acids, sugars or choline derivatives, DES are so called natural deep eutectic solvents (NADES) which fully comply with green technology principles(3). NADES constituted by bioactive substances or active pharmaceutical ingredients (APIs), which we define as therapeutic deep eutectic solvents (THEDES), are a promising source for several pharmaceutical and biomedical applications due to their increased ability to dissolve model drugs by increasing their solubility, permeation and absorption. In this work, we synthetized several THEDES based in choline chloride (ChCl) or menthol conjugated with three different APIs: acetylsalicylic acid (AA), benzoic acid (BA) and phenylacetic acid (PA) with different molar ratios (ChCl:AA 1:1, ChCl:PA 1:1, Menthol:AA 3:1, Menthol:BA 3:1, Menthol:PA 2:1, Menthol:PA 3:1). All THEDES produced were characterized by differential scanning calorimetry and polarized optical microscopy. Dissolution studies performed in PBS for 24 hours shown that THEDES increased significantly the dissolution of all APIs studied compared to the control (APIs only). This increased solubility was even more noticeable for the cases of THEDES with menthol in their composition. In overall, our results suggest the great promise of using THEDES as solubility enhancers in the development of novel and more effective drug delivery systems. |
|---|
Atividades financiadas
Não foram encontrados projetos financiados.